Insmed Inc
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | – | – | – | – | – | – | – | 24.6% | 18.9% | 16.4% | 16.6% | 19.0% | 22.9% | 23.4% | 24.3% | 26.2% | 24.5% | 23.9% | 21.8% | 23.7% | 23.0% | 25.1% | 19.9% | 22.0% | 21.2% | 21.5% | 21.1% | 22.0% | 23.1% | 23.2% | 22.7% | 25.0% | 22.9% | 26.1% | 20.6% | 16.8% | 16.2% | 15.8% | 16.7% | |
| – | – | – | – | – | – | – | – | – | 75.4% | 81.1% | 83.6% | 83.4% | 81.0% | 77.1% | 76.6% | 75.7% | 73.8% | 75.5% | 76.1% | 78.2% | 76.3% | 77.0% | 74.9% | 80.1% | 78.0% | 78.8% | 78.5% | 78.9% | 78.0% | 76.9% | 76.8% | 77.3% | 75.0% | 77.1% | 73.9% | 79.4% | 83.2% | 83.8% | 84.2% | 83.3% | |
| – | – | – | – | – | – | – | – | – | 405.9% | 142.5% | 111.9% | 88.3% | 71.4% | 98.2% | 84.1% | 94.9% | 163.7% | 152.7% | 142.5% | 150.5% | 136.0% | 158.8% | 135.7% | 147.5% | 210.4% | 196.1% | 255.0% | 138.0% | 163.7% | 160.4% | 162.4% | 161.4% | 172.1% | 164.4% | 165.0% | 131.0% | 96.6% | 68.5% | 49.4% | 75.7% | |
| – | – | – | – | – | – | – | – | – | 1,260.3% | 250.3% | 174.9% | 137.2% | 109.8% | 139.3% | 116.9% | 106.7% | 135.3% | 128.2% | 126.0% | 128.9% | 116.3% | 106.9% | 92.0% | 111.6% | 123.9% | 122.5% | 109.3% | 114.6% | 107.0% | 123.3% | 118.0% | 127.3% | 136.5% | 159.0% | 144.1% | 130.9% | 80.5% | 80.8% | 58.2% | 78.5% | |
| – | – | – | – | – | – | – | – | – | 991.9% | 398.4% | 291.0% | 228.7% | 184.0% | 240.9% | 203.9% | 204.5% | 302.0% | 284.0% | 271.3% | 299.8% | 252.9% | 246.2% | 210.3% | 268.6% | 333.4% | 306.0% | 383.5% | 265.6% | 291.0% | 269.6% | 396.6% | 305.8% | 295.6% | 344.4% | 365.1% | 336.5% | 177.9% | 149.3% | 84.6% | 155.1% | |
| – | – | – | – | – | – | – | – | – | -891.9% | -317.4% | -207.4% | -145.3% | -103.0% | -163.7% | -127.3% | -128.8% | -228.3% | -208.5% | -195.2% | -221.6% | -176.5% | -169.2% | -135.4% | -188.5% | -255.4% | -227.2% | -305.0% | -186.8% | -213.0% | -192.7% | -319.8% | -228.4% | -220.6% | -267.3% | -291.3% | -257.1% | -94.6% | -65.5% | -0.4% | -71.9% | |
| – | – | – | – | – | – | – | – | – | 67.8% | 30.7% | 22.6% | 17.6% | 16.1% | 20.1% | 17.6% | 16.5% | 18.1% | 18.8% | 22.7% | 24.0% | 20.2% | 6.2% | 5.1% | 5.0% | 27.7% | 30.7% | 26.7% | 25.7% | 24.8% | 27.9% | 23.5% | 22.5% | 20.6% | 23.2% | 19.8% | 14.3% | 7.8% | 6.6% | 4.8% | 7.1% | |
| – | – | – | – | – | – | – | – | – | -930.4% | -337.6% | -221.6% | -155.7% | -115.2% | -179.9% | -144.5% | -145.1% | -245.3% | -227.3% | -257.2% | -246.6% | -201.4% | -177.4% | -145.9% | -193.1% | -269.8% | -244.2% | -316.3% | -200.3% | -221.1% | -207.3% | -331.8% | -235.0% | -224.3% | -275.4% | -298.3% | -259.0% | -123.9% | -53.0% | -2.7% | -76.4% | |
| – | – | – | – | – | – | – | – | – | 0.7% | 1.0% | 0.3% | 0.4% | 0.7% | 0.1% | 1.0% | 0.7% | 1.5% | 0.6% | 1.4% | -5.5% | -0.1% | 0.7% | 0.8% | 0.5% | 0.2% | 0.7% | 0.7% | 0.7% | 1.2% | 0.8% | 0.9% | 1.1% | 1.2% | 1.0% | 1.2% | 0.9% | 0.6% | 0.5% | 0.4% | 0.5% | |
| – | – | – | – | – | – | – | – | – | -931.1% | -338.6% | -221.9% | -156.1% | -115.9% | -180.0% | -145.6% | -145.9% | -246.8% | -227.9% | -258.6% | -241.1% | -201.3% | -178.2% | -146.6% | -193.6% | -270.0% | -245.0% | -317.0% | -201.0% | -222.3% | -208.1% | -332.8% | -236.0% | -225.5% | -276.4% | -299.5% | -260.0% | -124.5% | -53.5% | -3.1% | -76.9% | |
| – | – | – | – | – | – | – | – | – | -829.8% | -297.9% | -192.1% | -133.2% | -92.9% | -151.3% | -119.5% | -121.4% | -219.4% | -200.3% | -227.5% | -215.0% | -176.1% | -168.0% | -138.6% | -186.2% | -243.0% | -212.3% | -288.4% | -172.7% | -194.2% | -177.1% | -306.5% | -210.3% | -202.7% | -250.8% | -276.6% | -242.8% | -114.5% | -44.8% | 3.3% | -67.8% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.